WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) reported increased media attention in 2017 on the company's Quell ® Wearable Pain Relief Technology™. An Inside Look at the Latest Health Tech - The Dr. Oz Show 3 Amazing New Gadgets to Relieve Aches & Pains - Fox News Could this

NeuroMetrix Files 510(k) for SENSUS(TM) Pain Therapy Device WALTHAM, Mass., Apr 18, 2012 (BUSINESS WIRE) --NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes reported today that it has filed a premarket

WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. ( NURO ), announced today that the Quell Wearable Pain Relief Device is now available on Amazon. "Most of our consumers are already on Amazon and appreciate the platform's convenience and first class customer service.

WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO), reported today that it has engaged CorProminence, LLC for investor relations services. CorProminence is a New York -based investor relations and strategic advisory firm with a business focus on small to mid-size companies.

WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) reported today that the United States Patent and Trademark Office has issued a Notice of Allowance for a patent application covering unique aspects of the Company's wearable pain relief technology.

WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. ( NURO ) today reported commercial expansion of DPNCheck ® in Mexico following receipt of a purchase order from one of Mexico's six major government healthcare institutions. With this most recent order, two of these six major institutions have

BOSTON --(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ:NURO) today announced that it has expanded distribution of the Quell Wearable Pain Relief device to The Grommet, a unique online product launch platform. "The Quell technology immediately stood out as a unique innovation that would appeal to our

Waltham -based company to exhibit its wearable device for widespread chronic pain relief BOSTON --(BUSINESS WIRE)-- NeuroMetrix, Inc.  (Nasdaq: NURO) is showing  Quell ® , its 100% drug-free Wearable Pain Relief Technology™ to sleep medicine professionals from around the world at SLEEP 2017 , the

WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (Nasdaq: NURO) announced that on the day after launch it had exceeded its Quell pre-order thirty day campaign goal. The Company reported preorders for over 500 Quell devices. Demand exceeded company projections and the initial offer sold out in

NeuroMetrix Enters Into Agreement with Simplex Healthcare for Distribution of the SENSUS Pain Management System WALTHAM, Mass. --(BUSINESS WIRE)--Sep. 24, 2013-- NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on management of chronic pain and peripheral neuropathies, today